Table 3.
Endpoints (n=123)
| n (%) | |
|---|---|
| Technical success | 120 (97.5) |
| Clinical success | 112 (91) |
| Stent primary dysfunction | 8 (6.5) |
| Biliary obstruction during follow-up (including primary stent dysfunction) | 20 (16) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.